Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Urogynecology Journal
Published in: International Urogynecology Journal 10/2019

01-10-2019 | Obesity | Images in Urogynecology

Utilization of CT for InterStim sacral neuromodulation lead placement in a patient with morbid obesity

Authors: Sierra M. Jansen, Benjamin Giertych, Christine Heisler

Published in: International Urogynecology Journal | Issue 10/2019

Login to get access

Excerpt

Stress, urge, and mixed urinary incontinence are associated with obesity [1]. InterStim sacral neuromodulation has been demonstrated to be a successful treatment modality for refractory urge incontinence in both normal and obese women [2]. Meissnitzer et al. previously described utilizing CT guidance in sacral neuromodulation lead placement primarily in patients with altered bony anatomy [3]. To our knowledge, we present the first case utilizing CT fluoroscopy guidance for InterStim lead placement due to morbid obesity. …
Literature
1.
Subak LL, Richter HE, Hunskaar S. Obesity and urinary incontinence: epidemiology and clinical research update. J Urol. 2009;182(6 Suppl):S2–7.PubMedPubMedCentral
2.
Levin PJ, Wu JM, Siddiqui NY, Amundsen CL. Does obesity impact the success of an InterStim test phase for the treatment of refractory urge urinary incontinence in female patients? Female Pelvic Med Reconstr Surg. 2012;18(4):243–6.CrossRef
3.
Meissnitzer T, Trubel S, Posch-Zimmermann R, Meissnitzer MW. CT-guided lead placement for selective sacral neuromodulation to treat lower urinary tract dysfunctions. AJR Am J Roentgenol. 2015;205(5):1139–42.CrossRef
Metadata
Title
Utilization of CT for InterStim sacral neuromodulation lead placement in a patient with morbid obesity
Authors
Sierra M. Jansen
Benjamin Giertych
Christine Heisler
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
International Urogynecology Journal / Issue 10/2019
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-019-03999-6

Other articles of this Issue 10/2019

International Urogynecology Journal 10/2019 Go to the issue

Review Article

Updating the evidence on drugs to treat overactive bladder: a systematic review

IUJ Video

Teaching learners to raise the roof: a vaginal surgery simulator for apical suspension

Original Article

External validation of de novo stress urinary incontinence prediction model after vaginal prolapse surgery

Original Article

Outpatient visits versus telephone interviews for postoperative care: a randomized controlled trial

Images in Urogynecology

Intravesical invasion of a Mersilene tape and secondary stone formation

Commentary

Commentary on “Risk factors and outcome of repair of obstetric anal sphincter injuries as followed up in a dedicated perineal clinic”